Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Current Topics in Medicinal Chemistry
|
August 19, 2007
The role of halogen bonding in inhibitor recognition and binding by protein kinases
Andrea Regier Voth, P Shing Ho
Proceedings of the National Academy of Sciences of the United States of America
|
March 24, 2007
Directing macromolecular conformation through halogen bonds
Andrea Regier Voth, Franklin A Hays, P Shing Ho
Nature Chemistry
|
March 8, 2011
Halogen bonds as orthogonal molecular interactions to hydrogen bonds
Andrea Regier Voth, Patricia Khuu, Keita Oishi, et al.
Journal of Molecular Recognition : JMR
|
April 1, 2006
The stacked-X DNA Holliday junction and protein recognition
Patricia A Khuu, Andrea Regier Voth, Franklin A Hays, et al.
Seminars in Oncology
|
September 25, 2016
Translating pharmacodynamic biomarkers from bench to bedside: analytical validation and fit-for-purpose studies to qualify multiplex immunofluorescent assays for use on clinical core biopsy specimens
Allison Marrero, Scott Lawrence, Deborah Wilsker, et al.
Seminars in Oncology
|
September 25, 2016
Immuno-pharmacodynamics for evaluating mechanism of action and developing immunotherapy combinations
Ralph E Parchment, Andrea Regier Voth, James H Doroshow, et al.
Nucleic Acids Research
|
September 22, 2018
Structural insights into the mechanism of double strand break formation by Hermes, a hAT family eukaryotic DNA transposase
Alison B Hickman, Andrea Regier Voth, Hosam Ewis, et al.
Biochemistry
|
June 25, 2013
Enthalpy-entropy compensation in biomolecular halogen bonds measured in DNA junctions
Megan Carter, Andrea Regier Voth, Matthew R Scholfield, et al.
Oncotargets and Therapy
|
March 3, 2022
PARP Inhibitor Applicability: Detailed Assays for Homologous Recombination Repair Pathway Components
Geraldine O'Sullivan Coyne, Chris Karlovich, Deborah Wilsker, et al.
Cancer Chemotherapy and Pharmacology
|
November 27, 2023
Pharmacodynamic effects of the PARP inhibitor talazoparib (MDV3800, BMN 673) in patients with BRCA-mutated advanced solid tumors
Arjun Mittra, Geraldine H O' Sullivan Coyne, Jennifer Zlott, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Current Topics in Medicinal Chemistry
|
August 19, 2007
The role of halogen bonding in inhibitor recognition and binding by protein kinases
Andrea Regier Voth, P Shing Ho
Proceedings of the National Academy of Sciences of the United States of America
|
March 24, 2007
Directing macromolecular conformation through halogen bonds
Andrea Regier Voth, Franklin A Hays, P Shing Ho
Nature Chemistry
|
March 8, 2011
Halogen bonds as orthogonal molecular interactions to hydrogen bonds
Andrea Regier Voth, Patricia Khuu, Keita Oishi, et al.
Journal of Molecular Recognition : JMR
|
April 1, 2006
The stacked-X DNA Holliday junction and protein recognition
Patricia A Khuu, Andrea Regier Voth, Franklin A Hays, et al.
Seminars in Oncology
|
September 25, 2016
Translating pharmacodynamic biomarkers from bench to bedside: analytical validation and fit-for-purpose studies to qualify multiplex immunofluorescent assays for use on clinical core biopsy specimens
Allison Marrero, Scott Lawrence, Deborah Wilsker, et al.
Seminars in Oncology
|
September 25, 2016
Immuno-pharmacodynamics for evaluating mechanism of action and developing immunotherapy combinations
Ralph E Parchment, Andrea Regier Voth, James H Doroshow, et al.
Nucleic Acids Research
|
September 22, 2018
Structural insights into the mechanism of double strand break formation by Hermes, a hAT family eukaryotic DNA transposase
Alison B Hickman, Andrea Regier Voth, Hosam Ewis, et al.
Biochemistry
|
June 25, 2013
Enthalpy-entropy compensation in biomolecular halogen bonds measured in DNA junctions
Megan Carter, Andrea Regier Voth, Matthew R Scholfield, et al.
Oncotargets and Therapy
|
March 3, 2022
PARP Inhibitor Applicability: Detailed Assays for Homologous Recombination Repair Pathway Components
Geraldine O'Sullivan Coyne, Chris Karlovich, Deborah Wilsker, et al.
Cancer Chemotherapy and Pharmacology
|
November 27, 2023
Pharmacodynamic effects of the PARP inhibitor talazoparib (MDV3800, BMN 673) in patients with BRCA-mutated advanced solid tumors
Arjun Mittra, Geraldine H O' Sullivan Coyne, Jennifer Zlott, et al.
Page
of 2